Lamar Odom’s Ups and Downs Through the Years: Khloe, Drugs, Kids

first_img“I’m just a different man now. You know what’s so crazy that you say that because I remember when I came out of the coma after the drug overdose], and I moved in the house in Calabasas in the same housing community that she lives in,” he told Us. “Because I was still damn near fried or just basically getting over being fried, I didn’t even know how to show her that I was empathetic, you know what I’m saying, and sorry and that I still loved her. I didn’t know how to go about it.”Scroll through to revisit Odom’s ups and downs: Life has been a roller coaster for Lamar Odom.The former professional basketball player’s career began in 1999 when he was drafted by the Los Angeles Clippers. Odom went on to play for the Miami Heat, Los Angeles Lakers and Dallas Mavericks over his nearly 15-year career in the NBA.- Advertisement – – Advertisement – “There’s no doubt in my mind that she’s the best mother ever because she took care of a 29-year-old man like he was a baby,” Odom told Us Weekly in May 2019. “I had every candy, cookie, juice, champagne, ice cream. I didn’t need anything and that’s just on the small scale. She made this room for me in our home. She’s an incredible homemaker, but all women in that family are.”He added at the time that he will “always” love Kardashian, who briefly withdrew her divorce papers and took care of him after he almost died following an overdose at a brutal in Nevada in 2015.- Advertisement – Shortly before he found success on the basketball court, Odom welcomed his first child, a daughter named Destiny, with his then-girlfriend Liza Morales. The twosome also share son Lamar Jr., who was born in 2002. Before Odom and Morales called it quits in 2006, she gave birth to a son named Jayden, who passed away at 6 months old of sudden infant death syndrome (SIDS).Odom’s personal life started making headlines in 2009 when he met Khloé Kardashian. After a whirlwind romance, the pair tied the knot in September 2009. Following a successful wedding episode of Keeping Up With the Kardashians, Odom and Kardashian launched a spinoff called Khloé & Lamar in 2011. The reality series ran for two seasons.While the twosome called it quits in December 2013 after four years of marriage amid Odom’s substance abuse issues, the athlete has only had kind words to say about his ex-wife, who shares daughter True with ex Tristan Thompson.- Advertisement –last_img read more

Moderna COVID-19 vaccine enters final stage trial this month

first_imgTopics : If they do get symptoms, the vaccine can still be considered a success if it stops severe cases of COVID-19.The study should run until October 27, according to its page on clinicaltrials.gov.The announcement came after the New England Journal of Medicine on Tuesday published results from the first stage of Moderna’s vaccine trial, which showed the first 45 participants all developed antibodies to the virus.Moderna, currently in the middle stage, is considered to be in a leading position in the global race to find a vaccine against the coronavirus, which has infected more than 13.2 million people and killed 570,000. China’s SinoVac is also at Phase 2.Russian news agency TASS on Sunday announced Russian researchers have completed clinical trials on a vaccine, though they have not shared their data.Scientists caution that the first vaccines to come to market may not be the most effective or safest. ‘Encouraging’ resultsModerna had previously published “interim results” from the first stages of its trial, called Phase 1, in a press release on its website in May.These revealed the vaccine had generated immune responses in eight patients, a result called “encouraging” by Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, which is co-developing the vaccine.But some in the scientific community said they would reserve judgment until they saw the full results in peer-reviewed form.According to the new paper, 45 participants were split into three groups of 15 each to test doses of 25 micrograms, 100 micrograms and 250 micrograms.They were given a second dose of the same amount 28 days later.After the first round, antibody levels were found to be higher with higher doses. Following the second round, participants had higher levels of antibodies than most patients who have had COVID-19 and gone on to generate their own antibodies.More than half the participants experienced mild or moderate side effects, which is considered normal. The side effects included fatigue, chills, headache, body ache and pain at the injection site.Three participants did not receive their second dose. They included one who developed a skin rash on both legs, and two who missed their window because they had COVID-19 symptoms, but their tests later returned negative.”The results look pretty good and look pretty consistent,” David Lo, a professor of biomedical sciences at University of California Riverside told AFP.But he cautioned that more work was needed to evaluate the vaccine’s safety — including making sure that it did not backfire by eventually making the immune system “tolerant” toward the real virus.Amesh Adalja, an infectious diseases specialist at Johns Hopkins University, added it was encouraging that the participants developed high levels of an advanced class of antibodies.He added, however: “You have to be very limited in how much you can extrapolate from a phase one clinical trial, because you want to see how this works when a person is exposed to the actual virus.”The Moderna vaccine belongs to a new class of vaccine that uses genetic material — in the form of RNA — to encode the information needed to grow the virus’s spike protein inside the human body, in order to trigger an immune response. The spike protein is a part of the virus that it uses to invade human cells, but by itself the protein is relatively harmless.The advantage of this technology is that it bypasses the need to manufacture viral proteins in the lab, shaving months off the standardization process and helping to ramp up mass production.No vaccines based on this platform have previously received regulatory approval. The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal.The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the vaccine at 100 microgram dose levels, and the other half to receive a placebo.It is designed to show whether the vaccine is safe and can prevent infection by the SARS-CoV-2 virus, or — if people still get infected — whether it can prevent the infection progressing toward symptoms. last_img read more

Heifers-Lost

first_img2 Heifers-Lost. One is all red and the other is red with a white face. Escaped on (9-15) Both are about 1-1/2 years old. We live on County Road 375 South off of Farmer’s Retreat Road.Please call 654-3148 or 621-8652 for details.last_img